NEUROBIOLOGY OF AGING, published by Elsevier Science Inc, is a premier journal dedicated to advancing our understanding of the complex interactions between the aging process and neurobiological mechanisms. With an ISSN of 0197-4580 and E-ISSN 1558-1497, the journal has established itself as a critical resource in the fields of Aging, Developmental Biology, Geriatrics and Gerontology, Clinical Neurology, and Neuroscience. Boasting a Q1 ranking in multiple categories, the journal is positioned within the top echelons of scholarly publication, underscoring its significant impact with an impressive Scopus ranking in various subfields. Committed to disseminating high-quality, peer-reviewed research, NEUROBIOLOGY OF AGING welcomes original articles, reviews, and research notes aiming to uncover the underlying processes of aging on the nervous system, fostering collaboration among researchers, professionals, and students alike. Although primarily subscription-based, the journal continues to play a vital role in shaping the discourse on aging and neurobiology, making it an essential publication for those engaged in this dynamic field.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, published by Wiley, stands as a leading resource in the field of geriatrics and gerontology. Established in 1953 and converging into a comprehensive academic platform through 2024, this esteemed journal is recognized for its high impact, holding a Q1 ranking in its category for 2023. It serves as a vital conduit for innovative research, clinical practices, and policy discussions aimed at improving the health and well-being of older adults. With a commitment to advancing geriatric medicine, the journal contributes significantly to the ongoing dialogue among researchers, healthcare professionals, and students dedicated to this rapidly evolving field. Although currently not offering open access options, the journal remains invaluable for those seeking to access pivotal studies and reviews that shape the future of geriatrics.

BIOGERONTOLOGY, published by SPRINGER, is a premier journal dedicated to the interdisciplinary study of biological aging processes and their implications for health and longevity. With an ISSN of 1389-5729 and an E-ISSN of 1573-6768, this journal features cutting-edge research that addresses critical questions in the fields of aging, geriatrics, and gerontology. Ranking impressively in the top quartiles, particularly as Q1 in Gerontology, BIOGERONTOLOGY is recognized for its contributions to advancing the understanding of aging at both molecular and systemic levels. The journal’s rich repository of scholarly articles provides valuable insights for researchers, healthcare professionals, and students alike, fostering a deeper comprehension of age-related biological mechanisms. Although not an open-access journal, it is highly regarded with an impact factor that reflects its significant role in the academic community. The journal spans from 2000 to 2024, ensuring a broad historical context for its studies, and is based in the Netherlands, with its administrative office located at One New York Plaza, Suite 4600, New York, NY 10004, United States. Engaging with BIOGERONTOLOGY means joining a global dialogue on the science of aging and the implications it holds for humanity.

Geriatrie et Psychologie Neuropsychiatrie du Vieillissement is a pivotal academic journal dedicated to the multidisciplinary study of aging, encompassing the fields of geriatrics, neuropsychiatry, and psychological health in the elderly population. Published by JOHN LIBBEY EUROTEXT LTD, this journal fosters knowledge dissemination and innovation, contributing to the understanding of the complexities faced by aging individuals. With a broad scope that includes biological psychiatry and neuropsychology, it serves as a vital resource for researchers, healthcare professionals, and students engaged in geriatric medicine and mental health. Although currently classified in the Q4 category across various relevant medical and psychological disciplines, the journal addresses critical topics that are essential for enhancing quality of care and improving patient outcomes. Additionally, the journal is accessible via open access options, promoting wide-ranging readership and collaboration within the academic community. As the field continuously evolves, Geriatrie et Psychologie Neuropsychiatrie du Vieillissement remains commited to pushing the boundaries of research and practice in gerontology and neuropsychiatry.

The Turkish Journal of Geriatrics (Türk Geriatri Dergisi), with ISSN 1304-2947 and E-ISSN 1307-9948, is a distinguished scholarly publication dedicated to the field of geriatrics and gerontology, proudly published by the Turkish Geriatrics Society. Established to foster knowledge and research in the aging population, this journal plays a crucial role in disseminating significant findings and advancements in the medical care of elderly individuals. Since its inception in 1998, the journal has committed to high-quality, peer-reviewed articles that explore diverse aspects of geriatric medicine, contributing vital insights to practitioners and researchers alike. Although it currently holds a Q4 ranking in the category of Geriatrics and Gerontology, the Turkish Journal of Geriatrics is on an upward trajectory, making it an essential resource for those specializing in the care of older adults. Researchers and professionals are encouraged to explore its rich archive and benefit from the open-access publishing model, promoting broader access to impactful research. For those invested in the well-being of the elderly, the Turkish Journal of Geriatrics serves not only as a platform for scholarly communication but also as a catalyst for innovation in geriatric care.

Geriatrics is a leading academic journal committed to advancing the understanding and research within the expansive field of gerontology and geriatric medicine. Published by MDPI since 2016 and featuring an Open Access model, this journal aims to disseminate high-quality research that addresses the challenges and opportunities associated with aging populations. Based in Switzerland, Geriatrics has rapidly gained recognition, achieving notable rankings in various categories such as Q2 in Gerontology and Q3 in both Aging and Geriatrics and Gerontology, making its contributions significant within the scholarly community. The journal welcomes original articles, reviews, and case studies, focusing not only on clinical aspects but also on social science perspectives related to health. Researchers and professionals in the field will find this journal a vital resource for the latest insights and trends that are crucial to improving elderly care and enhancing quality of life for aging individuals globally. With its commitment to open access, Geriatrics ensures that crucial research findings are readily available to all stakeholders, thus promoting informed dialogue and collaboration across disciplines.

The Lancet Healthy Longevity is a premier journal published by Elsevier that focuses on advancing our understanding of healthy aging and longevity through interdisciplinary research. Established in 2020, this Open Access journal is committed to disseminating innovative findings that enhance public and individual health, making it accessible to a global audience. The journal is proud to be recognized with a Q1 ranking in critical categories such as Family Practice, Geriatrics and Gerontology, Health (Social Science), and Psychiatry and Mental Health, indicating its prominent role in shaping contemporary discourse in these domains. As one of the leading titles within the field, it holds an influential position in Scopus rankings, with top placements in Geriatrics and Gerontology as well as Family Practice, thereby reaching the 99th percentile of scholarly impact. The Lancet Healthy Longevity aims to foster collaboration among researchers, healthcare professionals, and policymakers to promote healthy longevity, ultimately supporting the growing aging population worldwide. With its commitment to high-quality research and global accessibility, this journal is a vital resource for those dedicated to improving health outcomes across the lifespan.

Welcome to the European Journal of Geriatrics and Gerontology, a peer-reviewed platform dedicated to advancing knowledge and research in the fields of geriatrics and gerontology. Published by GALENOS PUBL HOUSE, this journal serves as a critical resource for researchers, healthcare professionals, and students who are involved in the care, treatment, and study of elderly populations. Since its inception in 2019 and running through 2024, the journal aims to foster interdisciplinary collaboration and disseminate innovative research that addresses the unique challenges faced by older adults. With an ISSN of 2687-2625, the journal is classified in the Q4 quartile of the Geriatrics and Gerontology category, signifying its emerging influence within the academic community, despite its current Scopus ranking of #113 out of 116, reflecting a rich opportunity for growth and visibility. Although the journal is not open access, it maintains a commitment to scholarly rigor and quality. Engage with the European Journal of Geriatrics and Gerontology to contribute to and learn from the evolving discourse in aging research.

Journals of Gerontology Series A: Biological Sciences and Medical Sciences, published by Oxford University Press Inc, stands at the forefront of aging research, bridging the gap between biological sciences and medical practices to address the complexities of gerontology. With an impressive impact factor reflecting its significant contribution to the field, this journal is recognized within the Q2 quartile in Aging and the Q1 quartile in Geriatrics and Gerontology for 2023, evidencing its high-quality scholarship and relevance. Researchers and professionals will find valuable insights through its comprehensive coverage of aging-related topics, informed by cutting-edge studies ranked among the top in their category—Rank #11 in Geriatrics and Gerontology and Rank #9 in Aging on Scopus. The journal aims to disseminate innovative research that can impact health care practices and enhance the quality of life in older populations. For those engaged in studies of aging, this journal offers a vital platform for sharing knowledge and advancing the understanding of biological and medical sciences as they pertain to gerontology.

DRUGS & AGING is a premier journal dedicated to the rapidly evolving field of geriatric pharmacology and the effective management of medications for older populations. Published by ADIS INT LTD, this journal stands out as a critical resource for researchers, healthcare professionals, and students focused on the intersection of aging and pharmacotherapy. With an impressive impact factor reflected in its ranking within the top quartile for both Geriatrics and Gerontology, and Q1 in Pharmacology (Medical), DRUGS & AGING provides a reputable platform for the dissemination of vital research from its inception in 1991 and extending through 2024. The journal features rigorous peer-reviewed articles, systematic reviews, and original research that cover a broad scope of topics, from medication efficacy in elderly patients to innovations in age-related drug therapies. As an influential publication with strong Scopus Ranks—positioned 90 out of 272 in Pharmacology and 41 out of 116 in Geriatrics—DRUGS & AGING plays an indispensable role in informing and advancing the effective and safe use of drugs in aging populations, ultimately aiming to improve the quality of life for older adults worldwide.